Program PDF Monday, March 30, 2020 Updated: 02-14-20

Program PDF Monday, March 30, 2020 Updated: 02-14-20

Program PDF Monday, March 30, 2020 Updated: 02-14-20 Acute and Stable Ischemic Heart Disease ‐ Scientific Acute and Stable Ischemic Heart Disease ‐ Oral Contributions Session #730 Session #909 Cardiogenic Shock ‐ Progress, Paradigms and Unresolved Problems Highlighted Original Research: Acute and Stable Ischemic Heart Monday, March 30, 2020, 8:00 a.m. ‐ 9:30 a.m. Disease and the Year in Review Room S504a Monday, March 30, 2020, 8:00 a.m. ‐ 9:30 a.m. CME Hours: 1.5 / CNE Hours: Room S505a CME Hours: 1.5 / CNE Hours: Co‐Chair: Erin Ann Bohula Co‐Chair: Sean Van Diepen Co‐Chair: Jamieson M. Bourque Co‐Chair: Pedro Moreno 8:00 a.m. Cardiogenic Shock: Where Are We in 2020? 8:00 a.m. Mir Basir Year in Review Speaker Detroit, MI Valentin Fuster New York, NY 8:10 a.m. SCAI Classification, Metrics And Monitoring of Cardiogenic Shock 8:12 a.m. Patrick R. Lawler MENTAL STRESS‐INDUCED MYOCARDIAL ISCHEMIA AS A MARKER FOR Toronto, Canada ADVERSE CARDIOVASCULAR EVENTS AFTER MI Zakaria Almuwaqqat, Bruno Lima, An Young, Samaah Sullivan, Amit J. Shah, 8:20 a.m. Muhammad Hammadah, Mariana Garcia, Oleksiy Levantsevych, Lisa Elon, Audience ARS Question: Pre Debate Poll Ernest Garcia, Doug Bremner, Paolo Raggi, Tene Lewis, Arshed A. Quyyumi, Erin Ann Bohula Viola Vaccarino, Emory University ‐ Rollins School of Public Health, Atlanta, Boston, MA GA, USA 8:22 a.m. 8:22 a.m. It’s Quite Clear, The Data Supports Culprit Only Revascularization in Shock! Discussion Holger Thiele Leipzig, Germany 8:25 a.m. LOW‐DENSITY NON‐CALCIFIED PLAQUE ON CORONARY CT ANGIOGRAPHY IS 8:32 a.m. THE STRONGEST INDEPENDENT PREDICTOR OF FUTURE MYOCARDIAL With All Due Respect of The Data, I Still Favor Complete Revascularization in INFARCTION Shock Michelle Williams, Jacek Kwiecinski, Mhairi Doris, Priscilla McElhinney, Mustafa Ahmed Michelle S. D'Souza, Sebastien J. Cadet, Philip D. Adamson, Alastair Moss, Birmingham, AL Shirjel Alam, Amanda Hunter, Anoop Shah, Nicholas L. Mills, Tania Pawade, Chengjia Wang, Jonathan Weir‐McCall, Giles Roditi, Edwin Van Beek, Leslee J. 8:42 a.m. Shaw, Edward David Nicol, Daniel S. Berman, Piotr Slomka, David E. Newby, Audience ARS Question: Post Debate Poll Marc Dweck, Damini Dey, BHF Centre for Cardiovascular Science, University Erin Ann Bohula of Edinburgh, Edinburgh, United Kingdom, Cedars‐Sinai Medical Center, Los Boston, MA Angeles, CA, USA 8:44 a.m. 8:35 a.m. Audience ARS Question: Pre‐Debate Poll Discussion Sean Van Diepen Edmonton, Canada 8:48 a.m. Discussion 8:47 a.m. Early Support, And The Right Support Does Make a Difference! 8:51 a.m. Erik Magnus Ohman LONG‐TERM OUTCOMES AFTER EMERGENCY REVASCULARIZATION FOR Durham, NC SPONTANEOUS CORONARY ARTERY DISSECTION Christina Thaler, Meagan Nowariak, Christian Schmidt, Elizabeth Grey, 8:57 a.m. Timothy D. Henry, Scott W. Sharkey, Minneapolis Heart Institute, Not so Fast: Show Me The RCT Data to Support Support in Shock! Minneapolis, MN, USA Judith S. Hochman New York, NY 9:01 a.m. Discussion 9:07 a.m. Audience ARS Question: Post‐Debate Poll 9:04 a.m. Sean Van Diepen LONG‐TERM OUTCOMES AFTER REVASCULARIZATION FOR STABLE ISCHEMIC Edmonton, Canada HEART DISEASE: AN INDIVIDUAL PATIENT‐LEVEL POOLED ANALYSIS OF 19 RANDOMIZED CORONARY STENT TRIALS 9:10 a.m. Mahesh Madhavan, Bjorn Redfors, Ziad Ali, Megha Prasad, Bahira Shahim, Panel Discussion With ARS Pieter Smits, Clemens von Birgelen, Zixuan Zhang, Roxana Mehran, Patrick Serruys, Akiko Maehara, Martin Leon, Ajay J. Kirtane, Gregg Stone, Cardiovascular Research Foundation, New York, NY, USA, Columbia University Medical Center, New York, NY, USA 9:14 a.m. Program PDF Monday, March 30, 2020 Updated: 02-14-20 Discussion Arrhythmias and Clinical EP ‐ Core Knowledge in Action Session #804 9:17 a.m. Core Knowledge in Action: Essentials of Atrial Fibrillation EFFECT ON PATIENT ADHERENCE TO PRIMARY PREVENTION Management ‐ Learn From the Experts RECOMMENDATIONS FOR STATIN THERAPY BASED ON THE NATIONAL Monday, March 30, 2020, 8:00 a.m. ‐ 9:30 a.m. GUIDELINES‐SUPPORTED POOLED COHORT RISK EQUATION OR A CORONARY Room S404d ARTERY CALCIUM SCORE: PRELIMINARY FINDINGS FROM THE VANGUARD CME Hours: 1.5 / CNE Hours: STUDY FOR THE CORCAL RANDOMIZED CLINICAL OUTCOMES TRIAL Chair: Hugh Calkins J. Brent Muhlestein, Kirk Knowlton, Viet T. Le, Donald Lappe, Heidi May, David Min, Kevin Johnson, Shanelle T. Cripps, Lesley H. Schwab, Shelbi B. 8:00 a.m. Braun, Tami Bair, Jeffrey L. Anderson, Intermountain Medical Center, Salt Basics of Atrial Fibrillation Explained Lake City, UT, USA, University of Utah, Salt Lake City, UT, USA Sanjiv M. Narayan Stanford, CA 9:27 a.m. Discussion 8:12 a.m. How to Evaluate the Patient with AF Arrhythmias and Clinical EP ‐ Scientific Brian Olshansky Session #731 Iowa City, IA The Direct Oral Anticoagulants For Stroke Reduction in AFib: Complex Dosing Strategies and Complicated Patients 8:24 a.m. Monday, March 30, 2020, 8:00 a.m. ‐ 9:30 a.m. Medical Management of AF Room S403b CME Hours: 1.5 / CNE Hours: John M. Mandrola Louisville, KY Co‐Chair: Craig J. Beavers Co‐Chair: Elaine M. Hylek 8:36 a.m. When Should I Refer for Ablation? 8:00 a.m. Melissa R. Robinson The DOAC Run‐Down: Guideline Consensus And Pharmacological Concerns Seattle, WA Mohamed Azzam Al Jaabari Abu Dhabi, United Arab Emirates 8:48 a.m. Putting it All Together‐ Review of 2019 ACC/AHA Focused Update of AF 8:12 a.m. Guideline The Use of DOACs in Renal Insufficiency: A Patient Case Cynthia M. Tracy Jared Frost Kensington, MD Milwaukee, WI 9:00 a.m. 8:24 a.m. Knowledge Check In via ARS Question and Answer Hugh Calkins Towson, MD 8:32 a.m. DOAC Use in Extreme Body Habitus Variability: A Patient Case 9:05 a.m. Sarah Slone Interactive Question and Answer Session With the Experts Columbia, SC Panelist: John M. Mandrola 8:44 a.m. Panelist: Sanjiv M. Narayan Question and Answer Panelist: Brian Olshansky Panelist: Melissa R. Robinson 8:52 a.m. Panelist: Cynthia M. Tracy DOACs And Surgery: When to Hold And When to Stop Rungroj Krittayaphong Congenital Heart Disease ‐ Oral Contributions Bangkok 10700, Thailand Session #910 Highlighted Original Research: Congenital Heart Disease and the 9:04 a.m. Year in Review Question and Answer Monday, March 30, 2020, 8:00 a.m. ‐ 9:30 a.m. Room S105b 9:12 a.m. CME Hours: 1.5 / CNE Hours: DOACs And Uncharted Territory: A Patient Case Peter Howard Stone Co‐Chair: Paul J. Chai BOSTON, MA Co‐Chair: Catherine D. Krawczeski 9:24 a.m. 8:00 a.m. Question and Answer Year in Review Speaker Jacqueline Kreutzer Pittsburgh, PA 8:12 a.m. Program PDF Monday, March 30, 2020 Updated: 02-14-20 THE IMPACT OF MORPHOLOGY ON SINGLE VENTRICLE FUNCTION, Heart Failure and Cardiomyopathies ‐ Scientific ATRIOVENTRICULAR VALVE COMPETENCY AND CLINICAL OUTCOMES IN Session #732 OVER 1,100 FONTAN PATIENTS: A 30 YEAR, SINGLE‐CENTER STUDY Challenging Cases in Cardio‐Oncology Jiyong Moon, Li Shen, Donald Likosky, Vikram Sood, Reilly D. Hobbs, Sassalos Monday, March 30, 2020, 8:00 a.m. ‐ 9:30 a.m. Peter, Jennifer C. Romano, Richard G. Ohye, Edward Bove, Ming‐Sing Si, Room S406a CME Hours: 1.5 / CNE Hours: University of Michigan, Ann Arbor, MI, USA Co‐Chair: Jean‐Bernard Durand 8:22 a.m. Co‐Chair: Daniel J. Lenihan Discussion Panelist: Cezar Iliescu 8:25 a.m. Panelist: Tochi M. Okwuosa THE INFLUENCE OF ANATOMICAL AND GENETIC FACTORS ON LONG‐TERM Panelist: Jo Rodgers OUTCOMES IN TETRALOGY OF FALLOT: A 35‐YEAR POPULATION‐BASED Panelist: Ronald Witteles COHORT 8:00 a.m. Samuel Blais, Ariane Marelli, Alain Vanasse, Christian Drolet, Adrian Dancea, Acute Coronary Syndrome Nagib Dahdah, Frederic Dallaire, Centre de Recherche du Centre Hospitalier Nicolas L. Palaskas Universitaire de Sherbrooke, Sherbrooke, Canada Houston, TX 8:35 a.m. 8:07 a.m. Discussion Acute Coronary Syndrome ‐ Case Presentation And Panel Discussion 8:38 a.m. 8:20 a.m. EXPOSURE TO LOW‐DOSE IONIZING RADIATION FROM CARDIAC Atrial Fibrillation And Anticoagulation PROCEDURES AND RISK OF MALIGNANCY IN CHILDREN WITH CONGENITAL Rupal P. O'Quinn HEART DISEASE Wynnewood, PA Elie Ganni, Aihua Liu, Liming Guo, Yixuan Li, Yajie Tian, Ariane Marelli, McGill University Health Centre, Montreal, Canada 8:27 a.m. Atrial Fibrillation And Anticoagulation ‐ Case Presentation And Panel 8:48 a.m. Discussion Discussion 8:39 a.m. 8:51 a.m. Acute Heart Failure MORBIDITY AND MORTALITY IN ADULT FONTAN PATIENTS REFERRED FOR Kathleen Zhang TRANSPLANT: A REPORT FROM THE FOSTER STUDY St Louis, MO Matthew J. Lewis, Christiane Haeffele, Sharon Chen, Leigh Reardon, Jamil A. Aboulhosn, Natalia Nugaeva, Heather Joan Ross, Yuli Kim, Richard A. 8:46 a.m. Krasuski, Anne Marie Valente, Matthew Carazo, Eric Krieger, Jilian Angiulo, Acute Heart Failure ‐ Case Presentation And Panel Discussion Wendy Book, Fred Rodriguez, Alexander Egbe, Roni Jacobson, Michael Earing, Jonathan W. Cramer, Ari M. Cedars, Jong Ko, Chris Broda, Peter Ermis, 8:58 a.m. Marlon Rosenbaum, Columbia University Medical Center, New York, NY, USA Chronic Heart Failure Joshua Mitchell 9:01 a.m. Saint Louis, MO Discussion 9:05 a.m. 9:04 a.m. Chronic Heart Failure ‐ Case Presentation And Panel Discussion DIGOXIN IS ASSOCIATED WITH IMPROVED TRANSPLANT‐FREE INTERSTAGE SURVIVAL IN HIGH‐RISK BUT NOT LOW‐RISK PATIENTS WITH HYPOPLASTIC 9:17 a.m. LEFT HEART SYNDROME (HLHS) Audience Question and Answer Tyler Brown, David Brown, James S. Tweddell, Katherine Bates, Carole Lannon, Jeffrey Anderson, Cincinnati Children's Hospital Medical Center, Heart Failure and Cardiomyopathies ‐ Scientific Cincinnati, OH, USA Session #733 Heart Failure, Left to Its Own Devices 9:14 a.m.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    86 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us